Antibody Therapy MarketThe global antibody therapy market is on a strong growth trajectory, projected to expand at a CAGR of ...

While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...

The global antibody drug conjugates market size was valued at USD 11.84 billion in 2024 and is projected to reach from USD 12.89 billion in 2025 to USD 25.38 billion by 2033, growing at a CAGR of 8.84 ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Genmab A/S (NASDAQ:GMAB), a Danish biotechnology company specializing in antibody therapeutics for cancer treatment, finds itself at a crucial juncture. With a strong portfolio of approved medicines ...

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

Chugai Pharm signs collaboration agreement with GSK's Global Health Unit for development of anti-dengue virus antibody: Tokyo Friday, January 31, 2025, 09:00 Hrs [IST] Chugai Phar ...

studies conducted over an eight-month period. Sixty-three volunteers ... and fourfold neutralizing antibody rises to this virus were observed in 2 men who were ill but not infected with Type ...

Cell plates, pre-coated with poly-L-lysine (Sigma-Aldrich), received the addition of 2×10 4 293T cells (ATCC) to each well. Following this, the virus-antibody mixture was introduced, and the plates ...

Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.

New research emphasizes the need for ongoing COVID-19 protection for people with weakened immune systems, with scalable tests ...

The residues with a SASA loss (ΔSASA) in binding of more than 1Å 2 were classified as interacting residues ... Our statistical analysis reveals a significant increase in the number of antigen-antibody ...